Many folks in NC can’t access Ozempic due to limited insurance coverage. But policy changes and falling prices may expand ...

In the wake of early evidence supporting the long-term health benefits of GLP-1 based medications to potentially reduce the ...

Despite its popularity, Ozempic often leads to temporary weight loss, carries serious side effects, and most users regain ...

The Food and Drug Administration is cracking down on copycat versions of Ozempic — the brand name of semaglutide — and ...

Ozempic is the version of Novo Nordisk's semaglutide ... GLP-1 agonists have evolved into powerful tools for weight management and broader cardiometabolic health. Yet, as their use skyrockets ...

The high monthly costs of GLP-1s — ranging from $1,000 to $1,500 — are placing considerable financial pressure on healthcare ...

An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...

GLP-1 drugs like Ozempic show widespread promise beyond weight loss/diabetes, but cost and supply limit broader adoption.

Denmark's Novo Nordisk faces mounting pressure — from cheap copycats to US tariff threats — putting its weight-loss empire at ...

Cardiovascular Benefits Insulin resistance is a major risk factor for cardiovascular disease. Studies have shown that Ozempic not only ... its potential as a broader metabolic health intervention.